Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Biogen Inc. News

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Biogen's ALS Drug Won't Move Forward After Trial Failures

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Breaking News

The Good Times Are Over for Startups

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk Throws Dogecoin a Lifeline

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

Disney Fans Angry, Excited About New Guardians of the Galaxy Ride

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora Cannabis Slashing Weed Capacity in Profitability Push

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.